AbbVie Inc - SIC # 2834 - PHARMACEUTICAL PREPARATIONS

Ticker Exchange SIC # Website Latest Ticker
ABBV New York 2834 https://www.abbvie.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for AbbVie Inc

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in AbbVie Inc. of Class Action Lawsuit and Upcoming Deadline - ABBV - Oct 22nd, 2018 6:05 pm
Positive Phase 2b Data for AbbVie's Upadacitinib Show Significant Induction of Clinical Remission and Response in Patients with Ulcerative Colitis - Oct 22nd, 2018 4:01 pm
AbbVie Falls 3% - Oct 22nd, 2018 11:20 am
3 Dividend Stocks That Pay You More Than Coca-Cola Does - Oct 21st, 2018 6:04 am
Investor Alert: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against AbbVie Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm - Oct 19th, 2018 5:10 pm
ABBV NOTICE ALERT: Rosen Law Firm Files Securities Class Action Lawsuit Against AbbVie Inc.; Important Deadline – ABBV - Oct 19th, 2018 3:54 pm
AbbVie CFO Chase to retire by mid-year 2019 - Oct 19th, 2018 1:26 pm
AbbVie names Robert Michael chief financial officer - Oct 19th, 2018 8:00 am
AbbVie CFO Bill Chase to retire - Oct 19th, 2018 7:31 am
What to Expect from Thermo Fisher’s Third-Quarter Earnings - Oct 19th, 2018 6:24 am
Deadline Alert: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against AbbVie Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm - Oct 18th, 2018 3:40 pm
Hagens Berman Reminds Investors in AbbVie Inc. (NYSE: ABBV) of the Firm’s Ongoing Investigation and the November 20, 2018 Securities Class Action Lead Plaintiff Deadline - Oct 18th, 2018 2:01 pm
FDA Accepts Application for AbbVie's Imbruvica in Specific Blood Cancers - Oct 18th, 2018 11:44 am
SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against AbbVie Inc. (ABBV) & Lead Plaintiff Deadline – November 20, 2018 - Oct 18th, 2018 8:00 am
AbbVie settles Humira biosimilar dispute with Fresenius Kabi - Oct 18th, 2018 7:56 am
AbbVie Announces Global Resolution of HUMIRA® (adalimumab) Patent Disputes with Fresenius Kabi - Oct 18th, 2018 6:50 am
Waltham's Morphic Therapeutic inks $100M deal with AbbVie - Oct 18th, 2018 6:24 am